REVIEW
Published on 07 Jul 2025
A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review
doi 10.3389/fendo.2025.1605746
- 847 views
- Frontiers in Endocrinology
- Cardiovascular Endocrinology
- Research Topics
- Preventing Cardiovascular Complications of Type 2 Diabetes - Volume II
Preventing Cardiovascular Complications of Type 2 Diabetes - Volume II
1,997
Total downloads
8,789
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 26 Jun 2025
Association of estimated glucose disposal rate with atrial fibrillation, heart failure and cardiovascular mortality in patients with diabetes:a prospective cohort study from the UK Biobank
doi 10.3389/fendo.2025.1579836
- 165 views
ORIGINAL RESEARCH
Published on 25 Jun 2025
Establishment of a synthetic ECV model and its prognostic value in diabetes patients with acute myocardial infarction
doi 10.3389/fendo.2025.1534236
- 527 views
ORIGINAL RESEARCH
Published on 19 Jun 2025
Association between glycemia risk index and carotid intima-media thickness in type 2 diabetes
doi 10.3389/fendo.2025.1563734
- 586 views
REVIEW
Published on 10 Jun 2025
Evaluation of three mechanisms of action (SGLT2 inhibitors, GLP-1 receptor agonists, and sulfonylureas) in treating type 2 diabetes with heart failure: a systematic review and network meta-analysis of RCTs
doi 10.3389/fendo.2025.1562815
- 2,094 views
ORIGINAL RESEARCH
Published on 21 Feb 2025
The triglyceride–glucose index is a promising predictor for the risk of cardiovascular disease in the diabetic population aged ≥60 years in the United States: a retrospective cohort study from NHANES (2007-2016)
doi 10.3389/fendo.2025.1475590
- 2,094 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: